Patents by Inventor John George Babish

John George Babish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions from
    Patent number: 9180155
    Abstract: Described are four, novel supercritical fluid extracts of Nigella sativa seeds containing about 0.01 to about 40% (w/w) thymoquinone that can be produced using commercial-scale quantities of N. sativa seeds. These formulations provide antioxidant, thermogenic, anti-inflammatory and other biological activities qualitatively and quantitatively distinct from thymoquinone alone and are useful as dietary supplements or therapeutics for inflammation-related disorders.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: November 10, 2015
    Assignee: Bio Nexus, Ltd
    Inventors: John George Babish, Linda M. Pacioretty, Jan Debenedetto
  • Novel compositions from Nigella sativa
    Publication number: 20150004266
    Abstract: Described are four, novel supercritical fluid extracts of Nigella sativa seeds containing about 0.01 to about 40% (w/w) thymoquinone that can be produced using commercial-scale quantities of N. sativa seeds. These formulations provide antioxidant, thermogenic, anti-inflammatory and other biological activities qualitatively and quantitatively distinct from thymoquinone alone and are useful as dietary supplements or therapeutics for inflammation-related disorders.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 1, 2015
    Inventors: John George Babish, Linda M. Pacioretty, Jan Debenedetto
  • Compositions from
    Patent number: 8535740
    Abstract: Described are four, novel supercritical fluid extracts of Nigella sativa seeds containing about 0.01 to about 40% (w/w) thymoquinone that can be produced using commercial-scale quantities of N. sativa seeds. These formulations provide antioxidant, thermogenic, anti-inflammatory and other biological activities qualitatively and quantitatively distinct from thymoquinone alone and are useful as dietary supplements or therapeutics for inflammation-related disorders.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: September 17, 2013
    Assignee: Bionexus, Ltd.
    Inventors: John George Babish, Linda M. Pacioretty, Jan Debenedetto
  • Novel compositions from Nigella sativa
    Publication number: 20110076346
    Abstract: Described are four, novel supercritical fluid extracts of Nigella sativa seeds containing about 0.01 to about 40% (w/w) thymoquinone that can be produced using commercial-scale quantities of N. sativa seeds. These formulations provide antioxidant, thermogenic, anti-inflammatory and other biological activities qualitatively and quantitatively distinct from thymoquinone alone and are useful as dietary supplements or therapeutics for inflammation-related disorders.
    Type: Application
    Filed: November 29, 2010
    Publication date: March 31, 2011
    Inventors: John George Babish, Linda M. Pacioretty, Jan Debenedetto